Genetic analysis of Hsp90 function in Cryptococcus neoformans highlights key roles in stress tolerance and virulence
Open accessAbstract
The opportunistic human fungal pathogen Cryptococcus neoformans has tremendous impact on global health, causing 181,000 deaths annually. Current treatment options are limited, and the frequent development of drug resistance exacerbates the challenge of managing invasive cryptococcal infections. In diverse fungal pathogens, the essential molecular chaperone Hsp90 governs fungal survival, drug resistance, and virulence. Therefore, targeting this chaperone has emerged as a promising approach to combat fungal infections. However, the role of Hsp90 in supporting C. neoformans pathogenesis remains largely elusive due to a lack of genetic characterization. To help dissect the functions of Hsp90 in C. neoformans, we generated a conditional expression strain in which HSP90 is under control of the copper-repressible promoter CTR4-2. Addition of copper to culture medium depleted Hsp90 transcript and protein levels in this strain, resulting in compromised fungal growth at host temperature; increased sensitivity to stressors, including the azole class of antifungals; altered C. neoformans morphology; and impaired melanin production. Finally, leveraging the fact that copper concentrations vary widely in different mouse tissues, we demonstrated attenuated virulence for the CTR4-2p-HSP90 mutant specifically in an inhalation model of Cryptococcus infection. During invasion and establishment of infection in this mouse model, the pathogen is exposed to the relatively high copper concentrations found in the lung as compared to blood. Overall, this work generates a tractable genetic system to study the role of Hsp90 in supporting the pathogenicity of C. neoformans and provides proof-of-principle that targeting Hsp90 holds great promise as a strategy to control cryptococcal infection.
AI snapshot
Written from the paper’s full text.
TL;DR
The authors generated a copper-repressible *CTR4-2p-HSP90* conditional mutant in *Cryptococcus neoformans* and used it to show that Hsp90 supports growth at host temperature, azole tolerance, stress responses, melanin production, and virulence in an inhalation mouse model. The work provides a genetic tool for studying this essential chaperone and proof-of-principle that Hsp90 is a promising antifungal target in cryptococcosis.
Key findings
- Copper-mediated repression of *HSP90* reduced Hsp90 protein by 60%–70% relative to wild type at 30°C and 37°C, caused a severe growth defect at 37°C, and increased sensitivity to fluconazole but not amphotericin B.
- Genetic or pharmacological Hsp90 compromise plus fluconazole caused an approximate 1 Log10 reduction in CFU after 24 h, indicating that Hsp90 inhibition enables fluconazole to kill *C. neoformans*.
- Hsp90 depletion increased sensitivity to SDS, MG132, low pH, benomyl, hydroxyurea, and methyl methanesulfonate; caused abnormal polarized growth with multinucleated elongated cells; impaired melanin production at 37°C; and increased capsule thickness at 30°C in mutants while copper reduced capsule thickness in wild type.
- In mice, the *CTR4-2p-HSP90* mutant showed attenuated virulence after intranasal inoculation (5 × 10^4 CFU) but no virulence defect after intravenous inoculation (1 × 10^4 CFU); *HSP90* expression was reduced in lung and increased in brain.
Methods
- The *CTR4-2p-HSP90* mutant was constructed in KN99α by replacing 111 bp upstream of the *HSP90* intron with a NAT-*CTR4-2* promoter cassette using TRACE/CRISPR-Cas9; two PCR-validated transformants from a single transformation were characterized.
- Phenotypic assays included spot dilution growth tests, E-test strips, fluconazole cidality CFU assays, propidium iodide microscopy, melanin production on dopamine medium, capsule measurement by India ink, and stress sensitivity panels.
- Mouse virulence used 8-week-old female A/J mice (n = 10 per group) inoculated intranasally with 5 × 10^4 CFU or intravenously with 1 × 10^4 CFU; survival was analyzed by Kaplan-Meier curves with log-rank tests, and in vivo *HSP90* expression was measured by qRT-PCR normalized to *TEF1* (n = 3 mice per group).
Limitations
- Stated: copper supplementation did not completely repress *HSP90* expression, and the authors note that alternative systems such as a tetracycline-repressible promoter might more tightly regulate *HSP90* and avoid copper-induced artifacts.
- Stated: at 37°C, Hsp90 depletion caused a cytokinesis defect that prevented assessment of capsule production under capsule-inducing conditions.
- Evident from the text: copper itself significantly reduced capsule thickness in wild-type cells, so copper-dependent effects may confound some phenotypes; residual Hsp90 in the mutant may also underestimate the full consequences of loss of function.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
0 of 63 cited sources checked · 0 supported · 0 flagged
- Findingown data§ Abstract
We generated a conditional expression strain of C. neoformans in which HSP90 is under control of the copper-repressible promoter CTR4-2.
“we generated a conditional expression strain in which HSP90 is under control of the copper-repressible promoter CTR4-2.”
- Also stated in: § Results · plain
“we constructed a conditional expression allele of HSP90 under control of the copper-suppressible promoter CTR4-2”
Quote in the paperSubstantial claim - Also stated in: § Results · plain
- Findingown data§ Results
In the CTR4-2p-HSP90 strain, supplementation with 25 μM CuSO4 significantly reduced HSP90 transcript levels at 37°C.
“While supplementation with 25 µM CuSO4 had no significant effect on HSP90 expression in the wild-type control, it significantly reduced HSP90 expression in both transformants.”
Quote in the paperSubstantial claim - Findingown data§ Results
Depletion of HSP90 increases sensitivity to benomyl, hydroxyurea, and methyl methanesulfonate at 37°C and 30°C.
“Depletion of HSP90 increased sensitivity to all three compounds at 37°C (Figure 3A) and 30°C (Supplementary Figure S4A)”
Quote in the paperSubstantial claim - Findingown data§ Results
Depletion of HSP90 increases sensitivity to SDS, MG132, and low pH at both 37°C and 30°C.
“an increase in sensitivity to SDS, MG132, and low pH was observed at both 37°C (Figure 3A) and 30°C (Supplementary Figure S3).”
Quote in the paperSubstantial claim - Findingown data§ Results
Addition of radicicol or HSP990 further exacerbates the growth defect of CTR4-2p-HSP90 strains in the presence of copper at both 37°C and 30°C.
“Addition of the structurally unrelated Hsp90 inhibitors radicicol or HSP990 further exacerbated the growth defect phenotype of the CTR4-2p-HSP90 strains in the presence of copper at both temperatures (Figure 1D and Supplementary Figure S2B)”
Quote in the paperSubstantial claim- Rests on an assumption: Radicicol and HSP990 specifically inhibit Hsp90 in C. neoformans.
- Findingown data§ Abstract
Depletion of Hsp90 impairs melanin production in C. neoformans.
“impaired melanin production.”
- Also stated in: § Introduction · plain
“impaired production of melanin, a key virulence trait.”
Quote in the paperSubstantial claim - Also stated in: § Introduction · plain
- Findingown data§ Results
Depletion of HSP90 increases sensitivity to fluconazole but not to amphotericin B in C. neoformans at both 37°C and 30°C.
“depletion of HSP90 increased sensitivity to fluconazole but not to amphotericin B compared with no-copper controls as well as the wild-type strain at both 37°C and 30°C (Figure 2A and Supplementary Figure S3A).”
Quote in the paperSubstantial claim - Findingown data§ Abstract
The CTR4-2p-HSP90 mutant shows attenuated virulence specifically in an inhalation model of Cryptococcus infection.
“we demonstrated attenuated virulence for the CTR4-2p-HSP90 mutant specifically in an inhalation model of Cryptococcus infection.”
- Also stated in: § Introduction · plain
“We observed attenuation in virulence only in an inhalation model where C. neoformans is exposed to the relatively high copper concentrations found in lung tissue during invasion and establishment of infection.”
Quote in the paperSubstantial claim- Rests on an assumption: Copper concentrations are relatively high in lung compared to blood in mice during infection, and the inhalation and systemic models expose the pathogen to high and low copper respectively.
- Also stated in: § Introduction · plain
- Findingown data§ Results
In the CTR4-2p-HSP90 strain, addition of copper resulted in a 60%-70% reduction in Hsp90 protein levels relative to wild-type at 30°C and 37°C.
“the addition of copper to the CTR4-2p-HSP90 strains resulted in a 60%–70% reduction relative to wild-type levels of Hsp90 after culture at either 37°C or 30°C”
Quote in the paperSubstantial claim - Findingown data§ Results
Both pharmacological inhibition and genetic suppression of HSP90 cause an approximate one Log10 reduction in CFU after 24 h of fluconazole exposure compared to the initial inoculum.
“Both pharmacological inhibition of Hsp90 (Figure 2C) and genetic suppression of HSP90 (Figure 2D) caused an approximate one Log10 reduction in CFU after 24 h of drug exposure compared to the initial inoculum”
Quote in the paperSubstantial claim- Rests on an assumption: Radicicol and HSP990 specifically inhibit Hsp90 in C. neoformans.
- Findingown data§ Results
Supplementation with the copper chelator BCS significantly increased HSP90 expression in the CTR4-2p-HSP90 strains compared to YPD medium alone.
“supplementation with the copper chelator bathocuproinedisulphonic acid (BCS) significantly increased HSP90 expression compared to YPD medium alone (Figure 1B)”
Quote in the paperSubstantial claim - Findingown data§ Results
The CTR4-2p-HSP90 mutant displays no virulence defect compared to wild type upon intravenous inoculation.
“the mutant displayed no virulence defect compared to wild type upon intravenous inoculation (Figure 4G)”
- Also stated in: § Discussion · plain
“we did not observe attenuated virulence for the mutant strain.”
Quote in the paperSubstantial claim - Also stated in: § Discussion · plain
- Findingnone given§ Discussion
Supplementation with even a high concentration of copper did not completely repress HSP90 expression.
“Although supplementation with even a high concentration of copper did not completely repress HSP90 expression”
Quote in the paperNot a substantial claim - Findingown data§ Discussion
The study generated the first conditional expression mutant for Hsp90 in C. neoformans.
“we generated the first conditional expression mutant for Hsp90”
Quote in the paperSubstantial claim- Rests on an assumption: Analogous experiments in C. neoformans have yet to be performed.
- Findingown data§ Results
Pharmacological inhibition of Hsp90 by HSP990 and radicicol reduces melanin production at 37°C.
“pharmacological inhibition of Hsp90 reduced melanin production at 37°C, supporting the role of Hsp90 in regulating this critical virulence phenotype (Figure 4B).”
Quote in the paperSubstantial claim - Findingown data§ Results
Depletion of HSP90 at 37°C under capsule-inducing conditions results in a morphology consistent with a cytokinesis defect.
“Under capsule-inducing conditions, depletion of HSP90 at 37°C resulted in a morphology consistent with a cytokinesis defect”
Quote in the paperNot a substantial claim - Findingreasoning§ Discussion
Addition of well-validated Hsp90 inhibitors further exacerbated the growth defect of the strains in the presence of copper.
“Addition of well-validated Hsp90 inhibitors further exacerbated the growth defect of the strains in the presence of copper”
Quote in the paperSubstantial claim - Findingown data§ Discussion
Hsp90 is required for growth at host-range temperature in C. neoformans.
“here we provided clear evidence that Hsp90 is required for growth at host-range temperature in C. neoformans”
Quote in the paperSubstantial claim - Findingown data§ Results
HSP90 expression is significantly reduced in the CTR4-2p-HSP90 mutant strain when isolated from the lung compared to the parental wild-type strain.
“HSP90 expression was significantly reduced in the CTR4-2p-HSP90 mutant strain when isolated from the lung (Figure 4E)”
Quote in the paperSubstantial claim - Findingown data§ Results
HSP90 expression is significantly increased in the CTR4-2p-HSP90 mutant when isolated from the brain.
“HSP90 expression was significantly increased in the CTR4-2p-HSP90 mutant when isolated from the brain (Figure 4E)”
Quote in the paperSubstantial claim - Findingown data§ Results
The CTR4-2p-HSP90 mutant displays significantly attenuated virulence relative to the wild-type control upon intranasal inoculation.
“we observed significantly attenuated virulence for this mutant relative to the wild-type control upon intranasal inoculation (Figure 4F)”
- Also stated in: § Discussion · plain
“We observed attenuated virulence in an inhalation infection model where the CTR4-2 promoter repressed HSP90 expression in lung tissue where copper levels are high (Ding et al. 2013).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Ding et al. 2013 source
Not checked in the free run.
- Also stated in: § Discussion · plain
- Findingown data§ Results
Copper-mediated suppression of HSP90 in CTR4-2p-HSP90 mutants causes a copper-dependent reduction in melanin production at 37°C, which is not observed in the wild-type control.
“We observed a copper-dependent reduction in melanin production in CTR4-2p-HSP90 mutants at 37°C, which was not observed in the wild-type control (Figure 4A)”
Quote in the paperSubstantial claim - Findingown data§ Discussion
Copper supplementation was sufficient to cause a severe growth defect upon culturing conditional mutants at 37°C.
“it was sufficient to cause a severe growth defect upon culturing conditional mutants at the physiological temperature of 37°C.”
Quote in the paperSubstantial claim - Findingreasoning§ Discussion
The CTR4-2 promoter offered, for the first time, the opportunity to directly assess Hsp90's involvement in C. neoformans virulence.
“Here, the CTR4-2 promoter offered, for the first time, the opportunity to directly assess Hsp90’s involvement in C. neoformans virulence.”
Quote in the paperSubstantial claim - Interpretationown data§ Results
Hsp90 plays a critical role in cellular growth in C. neoformans.
“Thus, Hsp90 plays a critical role in cellular growth in C. neoformans, and the CTR4-2 promoter system enables the study of HSP90 function in this pathogen.”
Quote in the paperSubstantial claim - Interpretationown data§ Results
Hsp90 plays a conserved role in cell cycle progression in C. neoformans.
“suggesting that Hsp90 plays a conserved role in cell cycle progression in C. neoformans.”
Quote in the paperSubstantial claim - Interpretationown data§ Results
Hsp90 modulates fluconazole susceptibility of C. neoformans.
“Hsp90 modulates fluconazole susceptibility of C. neoformans”
Quote in the paperSubstantial claim - Premisecitation§ Abstract
The role of Hsp90 in supporting C. neoformans pathogenesis remains largely elusive due to a lack of genetic characterization.
“However, the role of Hsp90 in supporting C. neoformans pathogenesis remains largely elusive due to a lack of genetic characterization.”
Quote in the paperSubstantial claim0 of 2 sources checked - Interpretationown data§ Results
Compromise of Hsp90 enables fluconazole to kill Cryptococcus cells.
“indicating that compromise of Hsp90 enables fluconazole to kill Cryptococcus cells.”
Quote in the paperSubstantial claim- Rests on an assumption: Radicicol and HSP990 specifically inhibit Hsp90 in C. neoformans.
- Interpretationown data§ Results
Hsp90 supports the virulence of C. neoformans.
“Hsp90 acts to support the virulence of C. neoformans”
Quote in the paperSubstantial claim- Rests on an assumption: Copper concentrations are relatively high in lung compared to blood in mice during infection, and the inhalation and systemic models expose the pathogen to high and low copper respectively.
- Premisecitation§ Introduction
Monotherapy with fluconazole results in poor outcome relative to amphotericin B and flucytosine combination therapy due to lack of early fungicidal activity and development of resistance.
“Monotherapy with fluconazole also results in poor outcome relative to amphotericin B and flucytosine combination therapy due to the lack of early fungicidal activity for fluconazole resulting in the development of resistance (Bicanic et al. 2009; Hope et al. 2019).”
Quote in the paperNot a substantial claim0 of 2 sources checked - Interpretationown data§ Abstract
The CTR4-2p-HSP90 strain is a tractable genetic system to study Hsp90 function in C. neoformans.
“Overall, this work generates a tractable genetic system to study the role of Hsp90 in supporting the pathogenicity of C. neoformans”
Quote in the paperSubstantial claim - Interpretationcitation§ Discussion
Depletion of HSP90 confirmed previous observations that Hsp90 modulates key virulence phenotypes and antifungal drug tolerance in C. neoformans.
“Utilizing the CTR4-2 promoter, depletion of HSP90 confirmed previous observations based on chemical inhibitors that Hsp90 modulates key virulence phenotypes and antifungal drug tolerance in C. neoformans (Cordeiro et al. 2016; Chatterjee and Tatu 2017).”
Quote in the paperSubstantial claim0 of 2 sources checked - Premisecitation§ Results
Copper concentrations vary widely in different tissues within a mammalian host.
“the copper transporter gene CTR4 is expressed by C. neoformans at a constant low level in fungus growing in the lungs of mice, but is expressed at a high level in fungus isolated from the central nervous system due to the different physiological copper concentrations present at these sites (Steen et al. 2003; Ding et al. 2013).”
Quote in the paperSubstantial claim0 of 2 sources checked - Study design and conductnone given§ Discussion
The study was unable to achieve complete transcriptional repression of Hsp90.
“we were unable to achieve complete transcriptional repression of the chaperone.”
Quote in the paperSubstantial claim - Interpretationown data§ Results
Hsp90 is important as an enabler of virulence in C. neoformans.
“Overall, the results strongly support the importance of Hsp90 as an enabler of virulence in C. neoformans.”
Quote in the paperSubstantial claim- Rests on an assumption: By intranasal inoculation, the fungus must first establish infection in the lungs prior to lethal systemic dissemination.
- Rests on an assumption: By intravenous inoculation, C. neoformans rapidly disseminates directly to the brain.
- Premisecitation§ Discussion
The copper suppressive promoter CTR4-2 has been employed to study essential gene functions both in vitro and in vivo.
“The copper suppressive promoter CTR4-2 has been employed to study essential gene functions both in vitro and in vivo, and thus was selected to regulate HSP90 expression in this study (Chayakulkeeree et al. 2007).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Chayakulkeeree et al. 2007 source
Not checked in the free run.
- Interpretationreasoning§ Discussion
Hsp90 is important for supporting the growth and survival of C. neoformans.
“confirming the important role of Hsp90 in supporting the growth and survival of C. neoformans.”
Quote in the paperSubstantial claim- Rests on an assumption: The poor potency of human-targeted inhibitors against fungi coupled with the toxicity associated with inhibiting host Hsp90 have precluded these compounds from being tested as antifungals in vivo.
- Interpretationown data§ Results
Hsp90 modulates melanin production in C. neoformans.
“suggesting that Hsp90 modulates melanin production in C. neoformans.”
Quote in the paperSubstantial claim - Premisecitation§ Discussion
Hsp90 functions as a signaling hub, stabilizing various signal transducers that modulate key fungal virulence phenotypes.
“Hsp90 functions as a signaling hub, stabilizing various signal transducers that modulate key fungal virulence phenotypes (Cowen and Lindquist 2005; Shapiro et al. 2009; O’Meara et al. 2019; Hossain et al. 2020).”
Quote in the paperSubstantial claim0 of 3 sources checked - Interpretationcitation§ Discussion
In the systemic infection model, HSP90 expression remained high due to the relatively low copper environment found in blood and brain.
“in the systemic infection model, HSP90 expression remained high due to the relatively low copper environment found in blood and brain (Champika 2018)”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Champika 2018
Not checked in the free run.
- Study design and conductreasoning§ Discussion
By relying on differential physiological copper concentrations within different tissues, the study was able to regulate HSP90 expression in vivo.
“By relying on differential physiological copper concentrations within different tissues, we were able to regulate HSP90 expression in vivo.”
Quote in the paperSubstantial claim - Premisecitation§ Discussion
Filaments induced by compromise of Hsp90 function pharmacologically, genetically, or by increasing proteolytic stress are multinucleate as a result of mis-regulation of cell cycle progression.
“Filaments induced by compromise of Hsp90 function pharmacologically, genetically, or by increasing proteolytic stress, are multinucleate as a result of mis-regulation of cell cycle progression (Veri et al. 2018; Hossain et al. 2020).”
Quote in the paperSubstantial claim0 of 2 sources checked - Interpretationown data§ Discussion
Hsp90 may have a conserved function in cell cycle progression in C. neoformans.
“suggesting Hsp90 may have a conserved function in cell cycle progression in C. neoformans.”
Quote in the paperNot a substantial claim
- May combine two claims. 17
- Classified as probably not a substantial claim. 32
- The quote only partly states this claim. 1
May combine two claims.
Findingown data§ ResultsDepletion of HSP90 causes abnormal polarized growth and multinucleate phenotypes in C. neoformans.
“Closer examination of the cells via microscopy revealed abnormal polarized growth in the CTR4-2p-HSP90 mutants in the presence of copper (Figure 3C and Supplementary Figure S4B), with cells often displaying multinucleate phenotypes (Figure 3C).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown data§ ResultsCopper-mediated repression of C. neoformans HSP90 causes a significant growth defect at 37°C and a marginal defect at 30°C.
“Copper-mediated repression of C. neoformans HSP90 caused a significant growth defect at 37°C (Figure 1D) and a marginal defect at 30°C (Supplementary Figure S2B).”
Quote in the paperSubstantial claimClassified as probably not a substantial claim.
Findingnone given§ DiscussionThere is a very short intergenic sequence between HSP90 and YPD1.
“there is a very short intergenic sequence between HSP90 and yet another essential gene, YPD1.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown data§ ResultsAt 30°C, addition of copper significantly reduces capsule thickness of the wild-type strain but significantly increases capsule thickness in both CTR4-2p-HSP90 mutants.
“at 30°C, addition of copper significantly reduced capsule thickness of the wild-type strain but caused a significant increase in capsule thickness in both CTR4-2p-HSP90 mutants (Figure 4, C and D).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown data§ ResultsThe reduction in melanin production by Hsp90 inhibition occurred at concentrations with minimal impact on growth, so it is not merely due to growth inhibition.
“this occurred at concentrations that had minimal impact on growth, highlighting that the reduction in melanin production was not merely due to growth inhibition.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown data§ DiscussionDepletion of HSP90 in C. neoformans results in an apparent cytokinesis defect and the formation of multinucleated elongated cells.
“we found that depletion of HSP90 in C. neoformans resulted in an apparent cytokinesis defect and the formation of multinucleated elongated cells”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone given§ Materials and methodsAll spot dilution experiments were performed in biological duplicate to confirm data reproducibility.
“All experiments were performed in biological duplicate to confirm data reproducibility.”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim. May combine two claims.
Premisecitation§ IntroductionHsp90 modulates key virulence traits in C. albicans, such as morphogenesis, and genetic compromise of Hsp90 leads to clearance of otherwise lethal Candida or Aspergillus infections in animal models.
“Hsp90 also modulates key virulence traits in C. albicans, such as the ability to undergo morphogenesis, and in animal models, genetic compromise of Hsp90 function leads to clearance of otherwise lethal Candida or Aspergillus infections (Cowen et al. 2009; Shapiro et al. 2009).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites Cowen et al. 2009
Not checked in the free run.
- cites Shapiro et al. 2009 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone given§ Materials and methodsThe plasmid was sequenced to confirm no mutations were introduced during the cloning steps.
“The plasmid was sequenced to confirm no mutations were introduced during the cloning steps.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Premisecitation§ IntroductionC. neoformans can develop resistance to all current antifungals by employing genetic, genomic, and adaptive biological strategies.
“C. neoformans is also able to develop resistance to all other current antifungals by employing a plethora of genetic, genomic, and adaptive biological strategies (Iyer et al. 2021).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Iyer et al. 2021 source
Not checked in the free run.
May combine two claims.
Study design and conductown data§ Materials and methodsIn vivo gene expression primers were validated to amplify C. neoformans genes specifically, as all primer pairs tested failed to amplify cDNA from mock-infected tissues.
“To ensure primers amplified C. neoformans genes specifically, we used cDNA from mock-infected mice administered PBS in lieu of fungal cells. All primer pairs tested failed to amplify cDNA from mock-infected tissues.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Premisecitation§ IntroductionTargeting Hsp90 is a powerful therapeutic strategy to combat fungal disease caused by Candida and Aspergillus species.
“Previous work has shown that targeting Hsp90 is a powerful therapeutic strategy to combat fungal disease caused by Candida and Aspergillus species (Cowen and Lindquist 2005; Cowen et al. 2009).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites Cowen and Lindquist 2005 source
Not checked in the free run.
- cites Cowen et al. 2009
Not checked in the free run.
May combine two claims. The quote only partly states this claim.
Interpretationown data§ ResultsHsp90 helps maintain protein homeostasis and genome stability in C. neoformans.
“Hsp90 helps maintain protein homeostasis and genome stability”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Premisecitation§ IntroductionThe copper-suppressible promoter CTR4-2 has been used previously to study function of the essential genes FAS1 and FAS2 in vivo.
“the copper-suppressible promoter CTR4-2, which has been used previously to study function of the essential genes FAS1 and FAS2 in vivo (Chayakulkeeree et al. 2007).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Chayakulkeeree et al. 2007 source
Not checked in the free run.
Classified as probably not a substantial claim. May combine two claims.
Premisecitation§ IntroductionHsp90 inhibition abrogates antifungal drug resistance and potentiates antifungal activity in fungi, notably by impairing signaling through calcineurin and the Pkc1 cell wall integrity pathway.
“Hsp90 inhibition abrogates antifungal drug resistance and potentiates antifungal activity through numerous mechanisms, most notably by impairing signaling through the protein phosphatase calcineurin and the Pkc1 cell wall integrity pathway (Cowen and Lindquist 2005; LaFayette et al. 2010; Singh-Babak et al. 2012; Caplan et al. 2018).”
Quote in the paperSubstantial claim0 of 3 sources checkedProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductcitation§ Materials and methodsThe Hsp90 antibody recognizes two bands, and the top band has been validated as Hsp90 using synthesized C. neoformans Hsp90 protein.
“The Hsp90 antibody recognizes two bands; the top band has been validated as Hsp90 using synthesized C. neoformans Hsp90 protein(Marcyk et al. 2021).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Marcyk et al. 2021 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone given§ Materials and methodsAll western blot experiments were performed in biological duplicate to confirm data reproducibility.
“All western blot experiments were performed in biological duplicate to confirm data reproducibility.”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim. May combine two claims.
Premisecitation§ ResultsMelanin and capsule production are two major virulence traits in C. neoformans.
“Melanin and capsule production are two major virulence traits in C. neoformans (Kwon-Chung et al. 2014).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Kwon-Chung et al. 2014 source
Not checked in the free run.
Classified as probably not a substantial claim. May combine two claims.
Premisecitation§ IntroductionThe molecular chaperone Hsp90 is conserved throughout eukaryotes and regulates diverse meta-stable signal transducers involved in sensing and responding to stress.
“The molecular chaperone Hsp90 is conserved throughout eukaryotes, where it regulates the function of diverse meta-stable signal transducers involved in sensing and responding to stress (Taipale et al. 2010; O’Meara et al. 2017).”
Quote in the paperSubstantial claim0 of 2 sources checkedClassified as probably not a substantial claim.
Study design and conductown data§ Materials and methodsTransformants were genotyped via PCR for the correct integration of the CTR4-2 promoter.
“Transformants were selected on YPD-NAT agar medium and genotyped via PCR for the correct integration of the CTR4-2 promoter.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone given§ Materials and methodsThe animal experiment protocols were approved by the Institutional Animal Care and Use Committee at the University of Iowa.
“The animal experiment protocols were approved by Institutional Animal Care and Use Committee at the University of Iowa (Protocol: 0092064).”
Quote in the paperNot a substantial claimMay combine two claims.
Premisecitation§ AbstractIn diverse fungal pathogens, Hsp90 governs fungal survival, drug resistance, and virulence.
“In diverse fungal pathogens, the essential molecular chaperone Hsp90 governs fungal survival, drug resistance, and virulence.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites Cowen and Lindquist 2005 source
Not checked in the free run.
- cites Cowen et al. 2009
Not checked in the free run.
May combine two claims.
Premisecitation§ IntroductionC. neoformans is intrinsically resistant to echinocandins, and treatment options remain limited to polyenes, azoles, and flucytosine.
“C. neoformans is intrinsically resistant to echinocandins, and therefore treatment options remain limited to polyenes, azoles, and the pyrimidine analog flucytosine that targets RNA and DNA synthesis (Denning 2003; Iyer et al. 2021).”
Quote in the paperNot a substantial claim0 of 2 sources checkedProbably not a substantial claim: may not pass S3 (load-bearing).
Interpretationcitation§ ResultsThe inhibition of capsule production by radicicol is likely the result of growth defects upon Hsp90 compromise in those conditions.
“which is likely the result of growth defects upon Hsp90 compromise in those conditions”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim.
Premisecitation§ ResultsIn C. albicans, genetic depletion of Hsp90 has provided proof-of-principle that targeting this chaperone has great therapeutic potential to treat systemic candidiasis.
“In C. albicans, genetic depletion of Hsp90 has provided proof-of-principle that targeting this chaperone has great therapeutic potential to treat systemic candidiasis (Cowen et al. 2009)”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Cowen et al. 2009
Not checked in the free run.
Classified as probably not a substantial claim.
Premisecitation§ DiscussionEssential genes required for survival serve as optimal targets for novel antifungal development.
“Essential genes that are required for survival serve as optimal targets for novel antifungal development (Iyer et al. 2021).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Iyer et al. 2021 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Premisecitation§ DiscussionIn C. albicans, Hsp90 client proteins include regulators that play important roles in cell-cycle progression and morphogenesis.
“In C. albicans, Hsp90 client proteins also include regulators that play important roles in cell-cycle progression and morphogenesis (Hossain et al. 2021).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Hossain et al. 2021 source
Not checked in the free run.
Classified as probably not a substantial claim. May combine two claims.
Premisecitation§ DiscussionHsp90 is a critical stress-response regulator that has shown great promise as an antifungal target in Candida and Aspergillus.
“Hsp90, a critical stress-response regulator that has shown great promise as an antifungal target in Candida and Aspergillus (Cowen and Lindquist 2005; Cowen et al. 2009).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites Cowen and Lindquist 2005 source
Not checked in the free run.
- cites Cowen et al. 2009
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Premisecitation§ DiscussionCalcineurin inhibitors synergize with fluconazole against C. neoformans.
“Calcineurin inhibitors also synergize with fluconazole against C. neoformans (Del Poeta et al. 2000)”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Del Poeta et al. 2000 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Premisecitation§ DiscussionIn several fungal species, including S. cerevisiae and C. albicans, it is estimated that ∼20% of open reading frames are essential.
“In several fungal species, including the model yeast Saccharomyces cerevisiae and the distantly related fungal pathogen C. albicans, it is estimated that ∼20% of the open reading frames in their genomes are essential (Winzeler et al. 1999; Segal et al. 2018).”
Quote in the paperNot a substantial claim0 of 2 sources checkedProbably not a substantial claim: may not pass S3 (load-bearing).
Premisecitation§ DiscussionIn C. albicans, Hsp90 modulates cellular responses to antifungals by stabilizing components of the Pkc1-MAPK and calcineurin stress-response pathways.
“In C. albicans, Hsp90 modulates cellular responses to antifungals by stabilizing components of the Pkc1-MAPK and calcineurin stress-response pathways (Cowen and Lindquist 2005; Cowen et al. 2009; Shapiro et al. 2009).”
Quote in the paperNot a substantial claim0 of 3 sources checkedProbably not a substantial claim: may not pass S1 (asserted), S3 (load-bearing).
Premisecitation§ ResultsPharmacological inhibition of Hsp90 by radicicol in nutrient-limited capsule-inducing media inhibits capsule production.
“previous reports that pharmacological inhibition of Hsp90 by radicicol in nutrient-limited capsule-inducing media inhibits capsule production”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites Cordeiro et al. 2016 source
Not checked in the free run.
- cites Chatterjee and Tatu 2017
Not checked in the free run.
Classified as probably not a substantial claim. May combine two claims.
Premisecitation§ DiscussionIn C. neoformans, calcineurin governs both morphogenesis during sexual reproduction and growth at host temperature.
“In C. neoformans, calcineurin governs both morphogenesis during sexual reproduction and growth at host temperature (Odom et al. 1997; Cruz et al. 2001).”
Quote in the paperSubstantial claim0 of 2 sources checkedProbably not a substantial claim: may not pass S3 (load-bearing).
Premisecitation§ DiscussionOnly a small number of essential genes have been identified and characterized in C. neoformans due to technical challenges of genetic manipulation.
“only a small number of essential genes have been identified and characterized in C. neoformans due to the technical challenges of genetic manipulation in this organism (Ianiri and Idnurm 2015; Iyer et al. 2021).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites Ianiri and Idnurm 2015
Not checked in the free run.
- cites Iyer et al. 2021 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Premisecitation§ DiscussionCalcineurin is a conserved nonessential protein phosphatase critical for morphogenesis, drug resistance, and virulence in multiple Candida species.
“Calcineurin is a conserved nonessential protein phosphatase critical for morphogenesis, drug resistance, and virulence in multiple Candida species (Cruz et al. 2002; Blankenship et al. 2003; Chen et al. 2011, 2012, 2014; Zhang et al. 2012).”
Quote in the paperNot a substantial claim0 of 3 sources checkedProbably not a substantial claim: may not pass S3 (load-bearing).
Premisecitation§ DiscussionIn C. albicans, Hsp90 modulates morphological transitions via the Ras1-PKA signaling pathway, as well as the cyclin-dependent kinase Pho85, cyclin Pcl1, and transcription factor Hms1.
“In C. albicans, Hsp90 modulates morphological transitions via the Ras1-PKA signaling pathway, as well as the cyclin-dependent kinase Pho85, cyclin Pcl1, and transcription factor Hms1 (Shapiro et al. 2009, 2012).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Shapiro et al. 2009, 2012
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Probably not a substantial claim: may not pass S3 (load-bearing).
Premisecitation§ DiscussionIn S. cerevisiae, cell cycle is regulated by the oscillatory expression of stage-specific cyclins that bind to and activate the master CDK Cdc28.
“In S. cerevisiae, cell cycle is regulated by the oscillatory expression of stage-specific cyclins that bind to and activate the master cyclin-dependent kinase (CDK) Cdc28 (Lew et al. 1997).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Lew et al. 1997
Not checked in the free run.
Classified as probably not a substantial claim.
Premisecitation§ DiscussionThe major pathway regulating titan cell formation is the cAMP/PKA/Rim101 signaling cascade.
“The major pathway regulating titan cell formation is the cAMP/PKA/Rim101 signaling cascade (Dambuza et al. 2018; Hommel et al. 2018; Trevijano-Contador et al. 2018)”
Quote in the paperSubstantial claim0 of 3 sources checkedMay combine two claims.
Premisecitation§ DiscussionUnique to C. neoformans, the cell cycle is differentially regulated during the formation of polyploid titan cells, which are gigantic cells that form inside host lungs and play important roles in pathogenesis, stress responses, and drug tolerance.
“Unique to C. neoformans, the cell cycle is differentially regulated during the formation of polyploid titan cells, which are gigantic cells that form inside host lungs and play important roles in pathogenesis, stress responses, and drug tolerance (Okagaki et al. 2010; Zaragoza et al. 2010).”
Quote in the paperSubstantial claim0 of 2 sources checkedProbably not a substantial claim: may not pass S3 (load-bearing).
Premisecitation§ DiscussionIn C. albicans, inhibition of Hsp90 destabilizes Cdc28 leading to cell cycle arrest and morphogenesis defects.
“In C. albicans, inhibition of Hsp90 destabilizes Cdc28 leading to cell cycle arrest and morphogenesis defects (Senn et al. 2012).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Senn et al. 2012 source
Not checked in the free run.
Classified as probably not a substantial claim.
Premisecitation§ DiscussionMany signal transducers in these pathways are regulated by Hsp90 in C. albicans.
“many signal transducers in these pathways are regulated by Hsp90 in C. albicans (O’Meara et al. 2017).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites O’Meara et al. 2017 source
Not checked in the free run.
Classified as probably not a substantial claim.
Premisecitation§ DiscussionCell cycle regulators Pho85 and Pcl1 have been shown to be involved in the endoreplication pathway during auto-diploidization in C. neoformans.
“Cell cycle regulators Pho85 and Pcl1 have also been shown to be involved in the endoreplication pathway during auto-diploidization in C. neoformans (Fu et al. 2021).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Fu et al. 2021
Not checked in the free run.
The paper relies on this without support.
Copper concentrations are relatively high in lung compared to blood in mice during infection, and the inhalation and systemic models expose the pathogen to high and low copper respectively.
“leveraging the fact that copper concentrations vary widely in different mouse tissues”
“selected because they were expected to expose the strain to either high or low concentrations of copper during the initial phase of infection.”
“the pathogen is exposed to the relatively high copper concentrations found in the lung as compared to blood.”
The paper relies on this without support.
Radicicol and HSP990 specifically inhibit Hsp90 in C. neoformans.
“Addition of the structurally unrelated Hsp90 inhibitors radicicol or HSP990 further exacerbated the growth defect phenotype”
“Both pharmacological inhibition of Hsp90 (Figure 2C) and genetic suppression of HSP90 (Figure 2D) caused an approximate one Log10 reduction”
The paper relies on this without support.
Analogous experiments in C. neoformans have yet to be performed.
“analogous experiments in C. neoformans have yet to be performed.”
The paper relies on this without support.
By intranasal inoculation, the fungus must first establish infection in the lungs prior to lethal systemic dissemination.
“By this route of administration, the fungus must first establish infection in the lungs prior to lethal systemic dissemination.”
The paper relies on this without support.
By intravenous inoculation, C. neoformans rapidly disseminates directly to the brain.
“By this route of administration, C. neoformans rapidly disseminates directly to the brain.”
The paper relies on this without support.
The poor potency of human-targeted inhibitors against fungi coupled with the toxicity associated with inhibiting host Hsp90 have precluded these compounds from being tested as antifungals in vivo.
“the poor potency of human-targeted inhibitors against fungi coupled with the toxicity associated with inhibiting host Hsp90 have precluded these compounds from being tested as antifungals in vivo.”
The paper relies on this without support.
The human fungal pathogen C. neoformans poses a major burden on human health, with treatment options limited to only two major antifungal classes.
“The human fungal pathogen C. neoformans poses a major burden on human health, with treatment options limited to only two major antifungal classes.”
The paper relies on this without support.
Another key trait of fungal pathogens is the ability to develop antifungal drug tolerance and resistance.
“Another key trait of fungal pathogens is the ability to develop antifungal drug tolerance and resistance.”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Depletion of HSP90 increases susceptibility to azoles as well as other cellular stressors in C. neoformans.
“Through the generation of a strain where levels of HSP90 could be repressed with a copper-repressible promoter, the authors showed depletion of HSP90 increases susceptibility to azoles as well as other cellular stressors in this pathogen79.”
From Molecular mechanisms governing antifungal drug resistance (2023) · cites this paper as [79]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Genotoxic-stress results assigned to two different Figure 3 panels
MinorThe text identifies Figure 3B as showing the tests with benomyl, hydroxyurea, and methyl methanesulfonate, but then cites Figure 3A for the 37°C results with those compounds.
“To examine whether this phenotype was conserved in C. neoformans, we also tested the wild-type strain and copper-regulated HSP90 mutants for sensitivity to the genotoxic stress-inducing agents benomyl, hydroxyurea, and methyl methanesulfonate (MMS) (Figure 3B and Supplementary Figure S4A).”
“Depletion of HSP90 increased sensitivity to all three compounds at 37°C (Figure 3A) and 30°C (Supplementary Figure S4A)”
Cites
Fiji: an open-source platform for biological-image analysis
Schindelin, J., Arganda-Carreras, I., Frise, E., Kaynig, V., Longair, M., Pietzsch, T., Preibisch, S., Rueden, C., Saalfeld, S., Schmid, B., et al. (2012) · Nature Methods · doi:10.1038/nmeth.2019 · Cited by 66,890 · see citing works
Enzymatic assembly of DNA molecules up to several hundred kilobases
Gibson, D. G., Young, L., Chuang, R.-Y., Venter, J. C., Hutchison, C. A., & Smith, H. O. (2009) · Nature Methods · doi:10.1038/nmeth.1318 · Cited by 9,742 · see citing works
Hidden Killers: Human Fungal Infections
Brown, G. D., Denning, D. W., Gow, N. A. R., Levitz, S. M., Netea, M. G., & White, T. C. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3004404 · Cited by 4,284 · see citing works
Winzeler, E. A., Shoemaker, D. D., Astromoff, A., Liang, H., Anderson, K., Andre, B., Bangham, R., Benito, R., Boeke, J. D., Bussey, H., et al. (1999) · Science · doi:10.1126/science.285.5429.901 · Cited by 3,953 · see citing works
Global burden of disease of HIV-associated cryptococcal meningitis: an updated analysis
Rajasingham, R., Smith, R. M., Park, B. J., Jarvis, J. N., Govender, N. P., Chiller, T. M., Denning, D. W., Loyse, A., & Boulware, D. R. (2017) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(17)30243-8 · Cited by 1,861 · see citing works
HSP90 at the hub of protein homeostasis: emerging mechanistic insights
Taipale, M., Jarosz, D. F., & Lindquist, S. (2010) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2918 · Cited by 1,818 · see citing works
Worldwide emergence of resistance to antifungal drugs challenges human health and food security
Fisher, M. C., Hawkins, N. J., Sanglard, D., & Gurr, S. J. (2018) · Science · doi:10.1126/science.aap7999 · Cited by 1,555 · see citing works
Denning, D. W. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14472-8 · Cited by 1,131 · see citing works
Antifungal Drug Resistance: Molecular Mechanisms in <i>Candida albicans</i> and Beyond
Lee, Y., Puumala, E., Robbins, N., & Cowen, L. E. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.0c00199 · Cited by 801 · see citing works
Self-citationHsp90 Potentiates the Rapid Evolution of New Traits: Drug Resistance in Diverse Fungi
Cowen, L. E., & Lindquist, S. (2005) · Science · doi:10.1126/science.1118370 · Cited by 698 · see citing works
Self-citationCombination Antifungal Therapy for Cryptococcal Meningitis
Day, J., Chau, T. T., Wolbers, M., Mai, P. P., Dung, N. T., Mai, N. H., Phu, N. H., Nghia, H. D. T., Phong, N. D., Cao, Q. T., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1110404 · Cited by 542 · see citing works
Cryptococcus neoformans and Cryptococcus gattii, the etiologic agents of cryptococcosis
Kwon-Chung, K. J., Fraser, J. A., Doering, T. L., Wang, Z. A., Janbon, G., Idnurm, A., & Bahn, Y.-S. (2014) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a019760 · Cited by 531 · see citing works
Calcineurin is required for virulence of Cryptococcus neoformans
Odom, A., Muir, S., Lim, E., Toffaletti, D. L., Perfect, J., & Heitman, J. (1997) · The EMBO Journal · doi:10.1093/emboj/16.10.2576 · Cited by 516 · see citing works
Roemer, T., Jiang, B., Davison, J., Ketela, T. W., Veillette, K., Breton, A., Tandia, F., Linteau, A., Sillaots, S., Marta, C., et al. (2003) · Molecular Microbiology · doi:10.1046/j.1365-2958.2003.03697.x · Cited by 513 · see citing works
Molecular Evolution of Antifungal Drug Resistance
Robbins, N., Caplan, T., & Cowen, L. E. (2017) · Annual Review of Microbiology · doi:10.1146/annurev-micro-030117-020345 · Cited by 441 · see citing works
Self-citationCowen, L. E., Singh, S. D., Köhler, J. R., Collins, C., Zaas, A. K., Schell, W. A., Aziz, H., Mylonakis, E., Perfect, J. R., Whitesell, L., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0813394106 · Cited by 413 · see citing works
Self-citationGlobal Warming Will Bring New Fungal Diseases for Mammals
Garcia-Solache, M. A., & Casadevall, A. (2010) · mBio · doi:10.1128/mbio.00061-10 · Cited by 370 · see citing works
Treatment strategies for cryptococcal infection: challenges, advances and future outlook
Iyer, K. R., Revie, N. M., Fu, C., Robbins, N., & Cowen, L. E. (2021) · Nature Reviews Microbiology · doi:10.1038/s41579-021-00511-0 · Cited by 363 · see citing works
Self-citationCryptococcal cell morphology affects host cell interactions and pathogenicity
Okagaki, L. H., Strain, A. K., Nielsen, J. N., Charlier, C., Baltes, N. J., Chrétien, F., Heitman, J., Dromer, F., & Nielsen, K. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1000953 · Cited by 345 · see citing works
Calcineurin is essential for survival during membrane stress in Candida albicans
Cruz, M. C., Goldstein, A. L., Blankenship, J. R., Del Poeta, M., Davis, D., Cardenas, M. E., Perfect, J. R., McCusker, J. H., & Heitman, J. (2002) · The EMBO Journal · doi:10.1093/emboj/21.4.546 · Cited by 342 · see citing works
LaFayette, S. L., Collins, C., Zaas, A. K., Schell, W. A., Betancourt-Quiroz, M., Gunatilaka, A. A. L., Perfect, J. R., & Cowen, L. E. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1001069 · Cited by 329 · see citing works
Self-citationHsp90 Orchestrates Temperature-Dependent Candida albicans Morphogenesis via Ras1-PKA Signaling
Shapiro, R. S., Uppuluri, P., Zaas, A. K., Collins, C., Senn, H., Perfect, J. R., Heitman, J., & Cowen, L. E. (2009) · Current Biology · doi:10.1016/j.cub.2009.03.017 · Cited by 311 · see citing works
Self-citationFungal cell gigantism during mammalian infection
Zaragoza, O., García-Rodas, R., Nosanchuk, J. D., Cuenca-Estrella, M., Rodríguez-Tudela, J. L., & Casadevall, A. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1000945 · Cited by 311 · see citing works
Raut, A. P., & Huy, N. T. (2021) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(21)00265-4 · Cited by 264 · see citing works
Experimental modulation of capsule size in Cryptococcus neoformans
Zaragoza, Ó., & Casadevall, A. (2004) · Biological Procedures Online · doi:10.1251/bpo68 · Cited by 231 · see citing works
Bicanic, T., Muzoora, C., Brouwer, A. E., Meintjes, G., Longley, N., Taseera, K., Rebe, K., Loyse, A., Jarvis, J., Bekker, L., et al. (2009) · Clinical Infectious Diseases · doi:10.1086/604716 · Cited by 227 · see citing works
Global Analysis of the Evolution and Mechanism of Echinocandin Resistance in Candida glabrata
Singh-Babak, S. D., Babak, T., Diezmann, S., Hill, J. A., Xie, J. L., Chen, Y.-L., Poutanen, S. M., Rennie, R. P., Heitman, J., & Cowen, L. E. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002718 · Cited by 204 · see citing works
Self-citationCalcineurin Is Essential for <i>Candida albicans</i> Survival in Serum and Virulence
Blankenship, J. R., Wormley, F. L., Boyce, M. K., Schell, W. A., Filler, S. G., Perfect, J. R., & Heitman, J. (2003) · Eukaryotic Cell · doi:10.1128/ec.2.3.422-430.2003 · Cited by 186 · see citing works
Cryptococcus neoformans Virulence Gene Discovery through Insertional Mutagenesis
Idnurm, A., Reedy, J. L., Nussbaum, J. C., & Heitman, J. (2004) · Eukaryotic Cell · doi:10.1128/ec.3.2.420-429.2004 · Cited by 185 · see citing works
Dambuza, I. M., Drake, T., Chapuis, A., Zhou, X., Correia, J., Taylor-Smith, L., LeGrave, N., Rasmussen, T., Fisher, M. C., Bicanic, T., et al. (2018) · PLoS Pathogens · doi:10.1371/journal.ppat.1006978 · Cited by 182 · see citing works
Cryptococcus neoformans copper detoxification machinery is critical for fungal virulence
Ding, C., Festa, R. A., Chen, Y.-L., Espart, A., Palacios, Ò., Espín, J., Capdevila, M., Atrian, S., Heitman, J., & Thiele, D. J. (2013) · Cell Host & Microbe · doi:10.1016/j.chom.2013.02.002 · Cited by 179 · see citing works
Del Poeta, M., Cruz, M. C., Cardenas, M. E., Perfect, J. R., & Heitman, J. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.3.739-746.2000 · Cited by 169 · see citing works
Cruz, M. C., Fox, D. S., & Heitman, J. (2001) · The EMBO Journal · doi:10.1093/emboj/20.5.1020 · Cited by 150 · see citing works
Segal, E. S., Gritsenko, V., Levitan, A., Yadav, B., Dror, N., Steenwyk, J. L., Silberberg, Y., Mielich, K., Rokas, A., Gow, N. A. R., et al. (2018) · mBio · doi:10.1128/mbio.02048-18 · Cited by 150 · see citing works
Hommel, B., Mukaremera, L., Cordero, R. J. B., Coelho, C., Desjardins, C. A., Sturny-Leclère, A., Janbon, G., Perfect, J. R., Fraser, J. A., Casadevall, A., et al. (2018) · PLoS Pathogens · doi:10.1371/journal.ppat.1006982 · Cited by 143 · see citing works
Fan, Y., & Lin, X. (2018) · Genetics · doi:10.1534/genetics.117.300656 · Cited by 136 · see citing works
Hsp90 orchestrates stress response signaling governing fungal drug resistance
Cowen, L. E. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000471 · Cited by 130 · see citing works
Self-citationCryptococcus neoformans can form titan-like cells in vitro in response to multiple signals
Trevijano-Contador, N., de Oliveira, H. C., García-Rodas, R., Rossi, S. A., Llorente, I., Zaballos, Á., Janbon, G., Ariño, J., & Zaragoza, Ó. (2018) · PLoS Pathogens · doi:10.1371/journal.ppat.1007007 · Cited by 124 · see citing works
<i>Cryptococcus neoformans</i> Gene Expression during Experimental Cryptococcal Meningitis
Steen, B. R., Zuyderduyn, S., Toffaletti, D. L., Marra, M., Jones, S. J. M., Perfect, J. R., & Kronstad, J. (2003) · Eukaryotic Cell · doi:10.1128/ec.2.6.1336-1349.2003 · Cited by 123 · see citing works
The histone H3-H4 tetramer is a copper reductase enzyme
Attar, N., Campos, O. A., Vogelauer, M., Cheng, C., Xue, Y., Schmollinger, S., Salwiński, Ł., Mallipeddi, N. V., Boone, B. A., Yen, L., et al. (2020) · Science · doi:10.1126/science.aba8740 · Cited by 117 · see citing works
Calcineurin controls drug tolerance, hyphal growth, and virulence in Candida dubliniensis
Chen, Y.-L., Brand, A., Morrison, E. L., Silao, F. G. S., Bigol, U. G., Malbas, F. F., Nett, J. E., Andes, D. R., Solis, N. V., Filler, S. G., et al. (2011) · Eukaryotic Cell · doi:10.1128/ec.00310-10 · Cited by 107 · see citing works
Chen, Y.-L., Konieczka, J. H., Springer, D. J., Bowen, S. E., Zhang, J., Silao, F. G. S., Bungay, A. A. C., Bigol, U. G., Nicolas, M. G., Abraham, S. N., et al. (2012) · G3 Genes|Genomes|Genetics · doi:10.1534/g3.112.002279 · Cited by 97 · see citing works
The Hsp90 chaperone network modulates Candida virulence traits
O’Meara, T. R., Robbins, N., & Cowen, L. E. (2017) · Trends in Microbiology · doi:10.1016/j.tim.2017.05.003 · Cited by 92 · see citing works
Unraveling the Biology of a Fungal Meningitis Pathogen Using Chemical Genetics
Brown, J. C. S., Nelson, J., VanderSluis, B., Deshpande, R., Butts, A., Kagan, S., Polacheck, I., Krysan, D. J., Myers, C. L., & Madhani, H. D. (2014) · Cell · doi:10.1016/j.cell.2014.10.044 · Cited by 84 · see citing works
Self-citationShapiro, R. S., Sellam, A., Tebbji, F., Whiteway, M., Nantel, A., & Cowen, L. E. (2012) · Current Biology · doi:10.1016/j.cub.2012.01.062 · Cited by 81 · see citing works
Self-citationAn efficiently regulated promoter system for Cryptococcus neoformans utilizing the CTR4 promoter
Ory, J. J., Griffith, C. L., & Doering, T. L. (2004) · Yeast · doi:10.1002/yea.1139 · Cited by 77 · see citing works
Hope, W., Stone, N. R. H., Johnson, A., McEntee, L., Farrington, N., Santoro-Castelazo, A., Liu, X., Lucaci, A., Hughes, M., Oliver, J. D., et al. (2019) · mBio · doi:10.1128/mbio.02575-19 · Cited by 70 · see citing works
Calcineurin Controls Hyphal Growth, Virulence, and Drug Tolerance of Candida tropicalis
Chen, Y., Yu, S.-J., Huang, H., Chang, Y.-L., Lehman, V. N., Silao, F. G. S., Bigol, U. G., Bungay, A. A. C., Averette, A. F., & Heitman, J. (2014) · Eukaryotic Cell · doi:10.1128/ec.00302-13 · Cited by 68 · see citing works
Senn, H., Shapiro, R. S., & Cowen, L. E. (2012) · Molecular Biology of the Cell · doi:10.1091/mbc.e11-08-0729 · Cited by 67 · see citing works
Self-citationA constitutively active GPCR governs morphogenic transitions in Cryptococcus neoformans
Hsueh, Y., Xue, C., & Heitman, J. (2009) · The EMBO Journal · doi:10.1038/emboj.2009.68 · Cited by 64 · see citing works
Cordeiro, R. D. A., Evangelista, A. J. D. J., Serpa, R., Marques, F. J. D. F., Melo, C. V. S. D., Oliveira, J. S. D., Franco, J. D. S., Alencar, L. P. D., Bandeira, T. D. J. P. G., Brilhante, R. S. N., et al. (2016) · Microbiology · doi:10.1099/mic.0.000222 · Cited by 63 · see citing works
Ianiri, G., & Idnurm, A. (2015) · mBio · doi:10.1128/mbio.02334-14 · Cited by 62 · see citing works
Zhang, J., Silao, F. G. S., Bigol, U. G., Bungay, A. A. C., Nicolas, M. G., Heitman, J., & Chen, Y. (2012) · PLoS ONE · doi:10.1371/journal.pone.0044192 · Cited by 61 · see citing works
Chatterjee, S., & Tatu, U. (2017) · PLOS Neglected Tropical Diseases · doi:10.1371/journal.pntd.0005836 · Cited by 57 · see citing works
Chayakulkeeree, M., Rude, T. H., Toffaletti, D. L., & Perfect, J. R. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00442-07 · Cited by 56 · see citing works
Yang, D., Jung, K., Bang, S., Lee, J.-W., Song, M.-H., Averette, A. F., Festa, R. A., Ianiri, G., Idnurm, A., Thiele, D. J., et al. (2016) · Genetics · doi:10.1534/genetics.116.190595 · Cited by 56 · see citing works
Caplan, T., Polvi, E. J., Xie, J. L., Buckhalter, S., Leach, M. D., Robbins, N., & Cowen, L. E. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.04.084 · Cited by 56 · see citing works
Self-citationIsolation and partial characterization of Hsp90 from Candida albicans.
Burt, E. T., Daly, R., Hoganson, D., Tsirulnikov, Y., Essmann, M., & Larsen, B. (2003) · PubMed · Cited by 51 · see citing works
Veri, A. O., Miao, Z., Shapiro, R. S., Tebbji, F., O’Meara, T. R., Kim, S. H., Colazo, J., Tan, K., Vyas, V. K., Whiteway, M., et al. (2018) · PLoS Genetics · doi:10.1371/journal.pgen.1007270 · Cited by 51 · see citing works
Self-citationO’Meara, T. R., O’Meara, M. J., Polvi, E. J., Pourhaghighi, M. R., Liston, S. D., Lin, Z.-Y., Veri, A. O., Emili, A., Gingras, A.-C., & Cowen, L. E. (2019) · PLoS Biology · doi:10.1371/journal.pbio.3000358 · Cited by 49 · see citing works
Self-citationLee, J.-W., Ko, Y.-J., Kim, S., et al. (2011) · Eukaryotic Cell · doi:10.1128/ec.05124-11 · Cited by 43 · see citing works
Marcyk, P. T., LeBlanc, E. V., Kuntz, D. A., Xue, A., Ortiz, F., Trilles, R., Bengtson, S., Kenney, T. M. G., Huang, D. S., Robbins, N., et al. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c01777 · Cited by 40 · see citing works
Self-citationAdvances in fungal chemical genomics for the discovery of new antifungal agents
Xue, A., Robbins, N., & Cowen, L. E. (2020) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.14484 · Cited by 37 · see citing works
Self-citationHossain, S., Veri, A. O., & Cowen, L. E. (2020) · mBio · doi:10.1128/mbio.00290-20 · Cited by 31 · see citing works
Self-citationHossain, S., Lash, E., Veri, A. O., & Cowen, L. E. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.108781 · Cited by 31 · see citing works
Three galactose inducible promoters for use in C. neoformans var. grubii
RUFF, J., Lodge, J. K., & Baker, L. G. (2008) · Fungal Genetics and Biology · doi:10.1016/j.fgb.2008.10.003 · Cited by 27 · see citing works
Fu, C., Davy, A., Holmes, S., Sun, S., Yadav, V., Gusa, A. A., Coelho, M. A., & Heitman, J. (2021) · PLoS Genetics · doi:10.1371/journal.pgen.1009935 · Cited by 21 · see citing works
Self-citationNargesi, S., Bongomin, F., & Hedayati, M. T. (2021) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0009092 · Cited by 20 · see citing works
Janbon, G. (2018) · Memórias do Instituto Oswaldo Cruz · doi:10.1590/0074-02760170519 · Cited by 16 · see citing works
Clinical Features of Acute Copper Sulphate Poisoning
Gamakaranage, C. S. K. (2018) · Journal of Heavy Metal Toxicity and Diseases · doi:10.21767/2473-6457.10021 · Cited by 4 · see citing works
Flagged first, then by citations
Research works printed but not linked: 1
- Lew, 1997, The Molecular and Cellular Biology of the Yeast Saccharomyces: Cell Cycle and Cell Biology, 607
Cited by
Sorted by citations
Molecular mechanisms governing antifungal drug resistance
Lee, Y., Robbins, N., & Cowen, L. E. (2023) · npj Antimicrobials and Resistance · doi:10.1038/s44259-023-00007-2 · Cited by 304 · see citing works
Self-citation
- Authors
- Fu, C., Beattie, S. R., Jezewski, A. J., Robbins, N., Whitesell, L., Krysan, D. J., & Cowen, L. E.
- Affiliations
- University of Toronto (CA)
- University of Iowa (US)
- Corresponding author
- Cowen, Leah E
- ORCID
- Venue
- Genetics
- Publisher
- Oxford University Press (OUP)
- Published
- 2021-10-09
- Volume
- 220
- Issue
- 1
- ISSN
- 0016-6731 (ISSN-L)
- 1943-2631
- PMC
- PMC8733452
- OpenAlex
- W3207753353
- Semantic Scholar
- e92ebc010876275a1ce11ef5d7308c1218239b71
- Cited by
- 31
- References
- 70
- Citations by year
- 2026: 3 · 2025: 13 · 2024: 7 · 2023: 7 · 2022: 1
- FWCI
- 3.96
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model (vor)
- Locations
- Genetics (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- F32 Postdoctoral Individual National Research Service Award (AI145160)
- T32 NINDS Institutional Research Training Grant (5T32AI007260)
- National Institute of Health (R01AI147541-01A1)
- Canadian Institutes of Health Research (FDN-154288)
- NIH R01 (R01AI120958)
- Canada Research Chair
- Microbial Genomics Infectious Disease
- Topics
- Health Sciences › Medicine › Epidemiology › Fungal Infections and Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Heat shock proteins research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fungal and yeast genetics research
- Keywords
- Cryptococcus neoformans, HSP90, molecular chaperones, conditional gene expression, fungal virulence, stress tolerance, melanogenesis, fungal morphology, drug resistance, antifungal drug targets
- MeSH terms
- Animals, Antifungal Agents, Copper, Cryptococcosis, Cryptococcus neoformans, Fungal Proteins, Stress, Physiological, Virulence, HSP90 Heat-Shock Proteins, Drug Resistance, Fungal, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-09.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-09.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review